Current Value
$1.871 Year Return
Current Value
$1.871 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
JOBY | 36.25% | $8.04B | +97.28% | 0.00% |
EYPT | 34.74% | $664.72M | +12.07% | 0.00% |
MLKN | 34.65% | $1.43B | -19.70% | 3.56% |
ZIMV | 34.18% | $279.49M | -46.07% | 0.00% |
TEX | 33.43% | $3.28B | -7.88% | 1.35% |
RXRX | 33.22% | $2.12B | -29.12% | 0.00% |
OVID | 32.97% | $23.50M | -56.03% | 0.00% |
KN | 32.90% | $1.57B | +6.47% | 0.00% |
TWST | 32.87% | $2.26B | -21.50% | 0.00% |
GPRO | 32.76% | $116.59M | -47.14% | 0.00% |
VERI | 31.86% | $66.41M | -39.57% | 0.00% |
RICK | 31.72% | $354.83M | +0.52% | 0.69% |
TWI | 31.50% | $691.83M | +52.74% | 0.00% |
WSC | 31.35% | $5.27B | -22.95% | 0.48% |
COHU | 31.25% | $953.77M | -38.54% | 0.00% |
AVXL | 31.18% | $902.38M | +156.55% | 0.00% |
IMNM | 30.99% | $750.92M | -28.80% | 0.00% |
CDZI | 30.91% | $250.54M | -0.65% | 0.00% |
ILMN | 30.85% | $15.88B | -4.69% | 0.00% |
HCAT | 30.80% | $282.58M | -34.30% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IWC | 38.15% | $818.14M | 0.6% |
ARKG | 37.64% | $1.02B | 0.75% |
PBW | 36.43% | $271.53M | 0.65% |
PBE | 35.60% | $223.19M | 0.58% |
XBI | 34.95% | $4.82B | 0.35% |
GNOM | 34.71% | $44.57M | 0.5% |
IBB | 33.70% | $5.26B | 0.45% |
IWM | 33.09% | $63.72B | 0.19% |
VTWO | 32.91% | $12.52B | 0.07% |
IWO | 32.90% | $11.60B | 0.24% |
GSSC | 32.88% | $561.54M | 0.2% |
KJUL | 32.11% | $119.50M | 0.79% |
PRNT | 32.00% | $76.77M | 0.66% |
KJAN | 31.88% | $287.30M | 0.79% |
PSC | 31.87% | $752.65M | 0.38% |
PRFZ | 31.86% | $2.36B | 0.34% |
PINK | 31.78% | $130.57M | 0.5% |
IWN | 31.69% | $10.96B | 0.24% |
ARKX | 31.45% | $341.31M | 0.75% |
ACES | 31.39% | $92.99M | 0.55% |
Finnhub
Fortress Biotech, Inc. dropped from Russell Microcap Growth Index...
Finnhub
Fortress Biotech, Inc. dropped from Russell 3000E Growth Index...
Yahoo
SCOTTSDALE, Ariz., June 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or the “Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the Company will join the small-cap Russell 2000® Index and the broad-market Russell 3000® Index, effec
Yahoo
Emrosi™ (DFD-29; 40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) demonstrated efficacy independent of body weight differences when treating rosaceaSCOTTSDALE, Ariz., June 20, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”) approved
Yahoo
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Fortress Biotech (FBIO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Yahoo
National TV Segment Highlights FDA-Approved Treatment for Rosacea Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET SCOTTSDALE, Ariz., June 09, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | 0.03% | $162.43M | 0.5% |
JPLD | 0.05% | $1.77B | 0.24% |
IBHE | -0.10% | $553.36M | 0.35% |
IBMN | 0.11% | $447.08M | 0.18% |
IEF | 0.13% | $34.88B | 0.15% |
PULS | 0.14% | $11.70B | 0.15% |
JPST | -0.14% | $31.90B | 0.18% |
CARY | -0.17% | $347.36M | 0.8% |
UTEN | 0.18% | $210.24M | 0.15% |
IBTP | -0.26% | $143.92M | 0.07% |
CGSD | -0.27% | $1.32B | 0.25% |
CMBS | -0.27% | $449.66M | 0.25% |
TYA | -0.28% | $152.69M | 0.15% |
TDTT | 0.32% | $2.64B | 0.18% |
CERY | -0.34% | $458.93M | 0.28% |
FTSD | 0.35% | $231.81M | 0.25% |
IBTO | -0.35% | $352.69M | 0.07% |
KRBN | -0.40% | $160.17M | 0.85% |
UUP | 0.44% | $201.63M | 0.77% |
USL | 0.45% | $42.23M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -25.56% | $296.22M | 1.43% |
VIXY | -21.14% | $164.54M | 0.85% |
TAIL | -19.08% | $99.63M | 0.59% |
ULST | -13.52% | $654.75M | 0.2% |
GBIL | -13.10% | $6.37B | 0.12% |
IBTG | -12.99% | $1.92B | 0.07% |
IVOL | -12.10% | $347.03M | 1.02% |
XONE | -11.68% | $625.28M | 0.03% |
TFLO | -11.64% | $6.82B | 0.15% |
BIL | -11.49% | $42.24B | 0.1356% |
IBTF | -11.43% | $1.99B | 0.07% |
SPTS | -11.17% | $5.80B | 0.03% |
XHLF | -10.83% | $1.73B | 0.03% |
XBIL | -9.77% | $783.90M | 0.15% |
CLIP | -8.91% | $1.51B | 0.07% |
IBTH | -8.38% | $1.62B | 0.07% |
UTWO | -7.84% | $379.52M | 0.15% |
FTSM | -7.77% | $6.37B | 0.45% |
SGOV | -6.46% | $49.21B | 0.09% |
IBDQ | -6.35% | $2.98B | 0.1% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VHC | -13.84% | $48.19M | +108.24% | 0.00% |
LITB | -8.58% | $21.24M | -78.57% | 0.00% |
CL | -8.19% | $74.88B | -3.64% | 2.19% |
HUSA | -7.74% | $19.66M | -19.53% | 0.00% |
STG | -7.23% | $30.78M | -22.51% | 0.00% |
K | -6.80% | $27.76B | +41.17% | 2.85% |
T | -6.42% | $203.71B | +51.55% | 3.92% |
MNOV | -5.41% | $62.29M | -9.29% | 0.00% |
PULM | -5.30% | $25.57M | +219.63% | 0.00% |
UNH | -5.02% | $279.00B | -37.22% | 2.74% |
CLX | -4.89% | $15.36B | -5.89% | 3.90% |
TIGO | -4.87% | $6.56B | +52.83% | 4.58% |
EW | -4.25% | $45.18B | -15.44% | 0.00% |
GFI | -4.07% | $21.56B | +57.55% | 2.31% |
CHD | -4.06% | $24.14B | -7.11% | 1.19% |
DFDV | -4.03% | $300.56M | +2,130.16% | 0.00% |
KMB | -3.86% | $43.92B | -3.75% | 3.75% |
TIMB | -3.62% | $9.76B | +41.79% | 1.97% |
TMUS | -3.29% | $269.58B | +33.04% | 1.38% |
MVO | -3.22% | $66.47M | -37.17% | 21.45% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RSG | -<0.01% | $74.28B | +22.81% | 1.20% |
KO | 0.01% | $305.22B | +11.97% | 2.81% |
CPRI | -0.02% | $2.14B | -45.60% | 0.00% |
MCK | -0.02% | $88.11B | +20.93% | 0.40% |
FATBB | -0.04% | $49.01M | -5.66% | 10.18% |
CIG | 0.09% | $3.77B | +11.48% | 0.00% |
ATUS | -0.09% | $977.55M | +1.46% | 0.00% |
DRD | 0.13% | $1.18B | +51.33% | 2.03% |
VIV | 0.14% | $18.81B | +44.82% | 0.66% |
SRRK | 0.18% | $3.38B | +357.53% | 0.00% |
SBS | 0.18% | $14.57B | +48.61% | 3.04% |
GRFS | -0.21% | $2.36B | +37.65% | 0.00% |
WST | -0.21% | $15.89B | -31.06% | 0.37% |
CMCSA | -0.24% | $133.78B | -5.83% | 4.43% |
CCI | 0.25% | $44.93B | +6.73% | 5.62% |
MSIF | -0.27% | $769.47M | +36.17% | 7.61% |
GOGL | 0.35% | $1.56B | -44.55% | 10.17% |
PRA | 0.36% | $1.17B | +89.68% | 0.00% |
PPL | 0.43% | $24.79B | +21.83% | 3.15% |
VRSK | 0.60% | $42.13B | +10.22% | 0.56% |